Home

Senores Pharmaceuticals Ltd EPS

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

EPS

₹ 12.72

Last updated on: May 16, 2025

Key Highlights

  • The Earning per Share of Senores Pharmaceuticals Ltd is ₹ 12.72 as of 16 May 25 .
  • The earning per share of Senores Pharmaceuticals Ltd changed from ₹ 4.01 to ₹ 3.81 over 4 quarters. This represents a CAGR of -4.99% .

Historical Earning per Share of Senores Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Senores Pharmaceuticals Ltd

Market Cap

2,287 Cr

EPS

12.7

P/E Ratio (TTM)

39.0

P/B Ratio (TTM)

2.9

Day’s High

519.95

Day’s Low

491.0

DTE

0.4

ROE

7.4

52 Week High

664.0

52 Week Low

440.0

ROCE

8.4

Market Price of Senores Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
16 May 2025496.7
15 May 2025541.1
14 May 2025541
13 May 2025546.15
12 May 2025509.85
09 May 2025486.95
08 May 2025481.7
07 May 2025493.95
06 May 2025496.55
05 May 2025505.4

BlinkX Score for Senores Pharmaceuticals Ltd

Asset Value vs Market Value of Senores Pharmaceuticals Ltd

Market Value

2,287

Asset Value

Value addition

7.6 X

266

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Senores Pharmaceuticals Ltd2287
Sun Pharmaceutical Industries Ltd416273
Divis Laboratories Ltd166750
Cipla Ltd121122
Torrent Pharmaceuticals Ltd110482
Mankind Pharma Ltd105963

Historical Market Cap of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Senores Pharmaceuticals Ltd News Hub

Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25

Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror

Read more

23 Jan 25

Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets

Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,

Read more

10 Jan 25

Senores Pharmaceuticals to hold board meeting

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 15 May 2025.

Read more

10 May 25

Senores Pharmaceuticals IPO subscribed 93.41 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a

Read more

24 Dec 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Senores Pharmaceuticals Ltd

What is the EPS of Senores Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Senores Pharmaceuticals Ltd is 12.72. An EPS is the amount of net income attributed to each share of a common stock.

How is Senores Pharmaceuticals Ltd EPS calculated?

The EPS of Senores Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Senores Pharmaceuticals Ltd report its EPS?

Senores Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Senores Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Senores Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Senores Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Senores Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions